Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.

Lee, J S; Wacholder, S; Struewing, J P; McAdams, M; Pee, D; Brody, L C; Tucker, M A; Hartge, P

Lee, J S; Wacholder, S; Struewing, J P; McAdams, M; Pee, D; Brody, L C; Tucker, M A; Hartge, P.

Affiliation

Lee JS; Howard Hughes Medical Institute, Bethesda, MD, USA.

J Natl Cancer Inst ; 91(3): 259-63, 1999 Feb 03.

Article in En | MEDLINE | ID: mdl-10037104

Subject(s)

Breast Neoplasms/ethnology; Breast Neoplasms/genetics; Breast Neoplasms/mortality; Genes, Tumor Suppressor/genetics; Jews/statistics & numerical data; Mutation; Adult; District of Columbia/epidemiology; Female; Genes, BRCA1/genetics; Humans; Linear Models; Middle Aged; Ovarian Neoplasms/ethnology; Ovarian Neoplasms/genetics; Ovarian Neoplasms/mortality; Survival Analysis; Survival Rate

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Jews / Genes, Tumor Suppressor / Mutation Limits: Adult / Female / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: J Natl Cancer Inst Year: 1999 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links